ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access
Sameera A. Alghamdi
Department of Biological Science, Faculty of Science, Princess Dr. Najla Bint Saud Al-Saud Center for Excellence Research in Biotechnology, King Abdulaziz University, Jeddah, Saudi Arabia.
J Pure Appl Microbiol. 2020;14(2):1431-1435 | Article Number: 6169
https://doi.org/10.22207/JPAM.14.2.41 | © The Author(s). 2020
Received: 17/03/2020 | Accepted: 05/05/2020 | Published: 20/06/2020
Abstract

Polycystic ovarian syndrome (PCOS) is a frequent disorder commonly found in reproductive-aged women. The disease PCOS in women is considered to be complex heterogeneity, which indicates the combined combination of genetics and environmental interaction factors. Insulin resistance, type 2 diabetes mellitus, and obesity are known to be the risk factors for the development of PCOS. The prevalence of obesity in Saudi Arabia is ripening equally in both men and women. Herbal Medicines are often used for the treatment of human diseases by traditional medicine. Herbal remedies are often used to treat PCOS women due to the similar effectiveness exists as Western anti-obesity drugs.  This study aimed to acknowledge the usage of herbal medicines for the prevention of obesity in PCOS women. This is a cross-sectional study carried out in reproductive-aged women in the Saudi population. PCOS women were provided with the questionnaire form if they are using the herbal products for the treatment of obesity. In this study, 85 PCOS women with obesity have been selected. The clinical and usage of herbal details have been recorded. In this study, 70.5% of women were using green tea, 19.8% and 11.7% were using the ginger and flax seeds. Turmeric, Capsicum and fenugreeks were used by 25.8%, 4.7% and 18.8% respectively. In conclusion, the PCOS women has high usage of green tea rather than other herbal medicines.

Keywords

Polycystic Ovarian Syndrome, Herbals, Obesity, Green-Tea

Article Metrics

Article View: 185
PDF Download: 45

Share This Article

© The Author(s) 2020. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.